Survey and comparative study to Evaluate the efficacy of Ayurvedic formulation and Shirodhara in Attention Deficit Hyperactivity Disorder.

Survey and Intervention study to Evaluate the efficacy of Ayurvedic formulation and Shirodhara in Attention Deficit Hyperactivity Disorder.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/014001

Enrollment

Registered

2018-05-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ADHD(Attention Deficit Hyperactivity Disorder)

Interventions

Intervention1: Tab ELEVA (Dr Vasisth pharma): Dose-1 Tablet twice a day with Honey after meal for 3 Month. Control Intervention1: Shirodhara: 15 days and followed by once in a week for 3 month in t

Eligibility

Inclusion criteria

Inclusion criteria: 1) School children aged between 6 to 12 years. 2) Having sign and symptoms for ADHD. 3) Children with average/normal IQ

Exclusion criteria

Exclusion criteria: 1) Children with known physical disability ( deafness or visual problems) 2) Children with psychiatric disorders. 3) Children with gross brain damage causing mental retardation. 4) Children with any genetic disorder 5) Children with • Epilepsy • on chronic medication(e.g. steroids) • previous history of an infectious disease involving central nervous system (e.g. encephalitis) • intellectual disability • autism 6) Unreliable history.

Design outcomes

Primary

Measure	Time frame
1) To study the prevalence of ADHD in school children (6-12 years) in Jaipur, Rajasthan. 2) To study the gender difference in prevalence of ADHD. 3) To assess the efficacy of tab. Eleva and Shirodhara in Attention Deficit Hyperactivity Disorder. Timepoint: 3 months	—

Secondary

Measure	Time frame
To provide relief in the symptoms of ADHDTimepoint: 3 Months	—

Countries

India

Contacts

Public ContactDr Omprakash Bairwa

NATIONAL INSTITUTE OF AYURVEDA, JAIPUR

op.muskan@gmail.com9005352090

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026